Date and time: Monday, 01.07.2024, 14:05-14:35

Location: Scientific Theatre

The session will introduce the audience to the European Brain Council (EBC) and its activities. As a network of key stakeholders in the EU brain space including neurologists, psychiatrists and neurosurgeons, neuroscientists, neurological and mental patient advocates and industry partners, EBC aims to foster collaboration in brain health, research and innovation, promote the translation of research breakthroughs in the clinical practice and bridge the gap between scientists and EU policymakers. EBC also deploys his mission by gathering the EU brain community at its annual event, Brain Innovation Days, and through its involvement in EU-funded research projects including BRAINTEASER – Bringing artificial intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis. BRAINTEASER exploits the value of AI and big data to advance remote monitoring and clinical decision making in Multiple Sclerosis and Amyotrophic Lateral Sclerosis. The audience will have a glimpse of BRAINTEASER clinical tool and models in the second presentation. The second speaker will also discuss some preliminary results.

Lecture Title: European Brain Council: Uniting MS and ALS Research Innovations through Collaborative Endeavours

Dieyenaba joined EBC in March 2023. As Project Officer, she mainly supports the application for prospective EU projects and the delivery of ongoing ones. Within the EBC Value of Treatment initiative, she also coordinates the case study on Chronic Pain disorders.

Dieyenaba has a biomedicine background focused on human nutrition. Through a science page, she popularises nutrition science promoting healthier food and lifestyle choices. Her interests include nutritional neuroscience and healthy ageing.

During her time at the European Pain Federation EFIC, Dieyenaba also gained experience in communications and advocacy at the EU level.

Lecture Title:Bringing Artificial Intelligence home for a better care of ALS and MS: the BRAINTEASER Project

Umberto Manera is Assistant Professor and Neurologist at the “Rita Levi Montalcini” Department of Neuroscience of the University of Turin and the Neurology Unit of “Città della Salute e della Scienza di Torino”. He has been working at the ALS Center in Turin since 2010. He mainly deals with clinical research on ALS. His scientific activity includes several topics, including neuroepidemiology, the evaluation of disease phenotypes and respiratory function assessment measures, biomarkers, neuroimaging. He also works as a sub-investigator for various randomized clinical trials. He is currently co-author of more than 110 scientific articles published in international peer-reviewed journals.